Biogen Idec, GNS target personalized medicine

Thursday, March 17, 2011 11:53 AM

Using a patient dataset and high-horsepower computing, researchers at Biogen Idec and analytics company GNS Healthcare have built a rheumatoid arthritis disease model that lets them run patient-specific virtual clinical trials, according to Fierce Biotech IT. This personalized-medicine stepping stone yields dynamic disease models of individualized patient outcomes.

The model generates predictions of the RA-sufferer's response to drugs, and the response to inhibiting drug targets and disease pathways. That's a first, said Colin Hill, CEO at GNS.

The collaborators used a patient dataset comprising genotyping, whole-blood gene expression profiles and such clinical measures as tender joints, swollen joints and C-reactive protein. They fed the data into GNS's supercomputer-driven platform, REFS (reverse-engineering and forward-simulation). REFS built the model.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs